Oct 5 2020 |
COVID-19: Provider Relief Fund General Distribution – Phase 3 |
Foley & Lardner LLP |
Oct 3 2020 |
HHS Releases Rural Action Plan |
Sheppard, Mullin, Richter & Hampton LLP |
Oct 2 2020 |
McDermottPlus Check-Up: October 2, 2020 |
McDermott Will & Schulte LLP |
Oct 2 2020 |
New York State Paid Sick Leave Takes Effect; New York City Amends Local Law to Conform, Impose Additional Requirements |
Robinson & Cole LLP |
Oct 2 2020 |
OSHA COVID-19 Enforcement on the Rise |
Jackson Lewis P.C. |
Oct 2 2020 |
COVID-19 Weekly Newsletter: POTUS Tests Positive, Pharma Pushes Back on Vaccine Politics |
Faegre Drinker |
Oct 2 2020 |
COVID-19 Related Workplace Deaths: Preparedness and Implementation is Key |
Barnes & Thornburg LLP |
Oct 2 2020 |
DOJ Creates National Rapid Response Strike Force As Focus on Health Care Fraud Continues to Grow |
Polsinelli PC |
Oct 2 2020 |
42 States and District of Columbia Enter into $39.5 Million Agreement with Anthem to Settle Breach-Related Claims |
Hunton Andrews Kurth |
Oct 2 2020 |
Philadelphia Expands Paid Sick Leave During COVID-19 |
Faegre Drinker |
Oct 2 2020 |
Athens Orthopedic Settles with OCR for $1.5M for Data Breach |
Robinson & Cole LLP |
Oct 2 2020 |
OCR Imposes Fines on Health Plan, Business Associate, and Physician Group Related to Hacking Incidents; Warns Providers of Malware Attack. |
Greenberg Traurig, LLP |
Oct 1 2020 |
California Expands Family and Medical Leave Law |
Hunton Andrews Kurth |
Oct 1 2020 |
Focus on Life Sciences After the Curve [PODCAST] |
McDermott Will & Schulte LLP |
Oct 1 2020 |
Nondiscrimination on the Basis of Sexual Orientation and Gender Identity: Issues for Employer Group Health Plans |
Varnum LLP |
Oct 1 2020 |
CMS Proposes Medicare Coverage Pathway for FDA-Designated Breakthrough Technologies |
Polsinelli PC |
Oct 1 2020 |
Florida Enters Phase 3, Reopens Bars and Restaurants |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Sep 30 2020 |
Blocking and Tackling: What Every Health Care Provider's Legal, IT, and Compliance Teams Need to Know About Information Blocking to Make It Through the First Compliance Deadline's Goal Posts |
K&L Gates LLP |
Sep 30 2020 |
Georgia is Ground Zero for Telemedicine Fraud |
Polsinelli PC |
Sep 30 2020 |
Maryland Adopts Daubert Standard for Expert Testimony: Fallout from Jurisprudential Drift |
Wilson Elser Moskowitz Edelman & Dicker LLP |
Sep 30 2020 |
HHS Provider Relief Updates |
Greenberg Traurig, LLP |
Sep 30 2020 |
Governor Signs Legislation Requiring Provision and Maintenance of Personal Protective Equipment for Health Care Employees Due to Covid-19 |
Jackson Lewis P.C. |
Sep 30 2020 |
HIPAA Business Associate Pays $2.3 Million Settlement After Hackers Target PHI of Over 6 Million Individuals |
Robinson & Cole LLP |
Sep 30 2020 |
A Year of Living Dangerously: 2020 and Maneuvers on the 340B Drug Pricing Program Battlefield |
Sheppard, Mullin, Richter & Hampton LLP |
Sep 29 2020 |
CMS Delays Publication of Final Rule Implementing Stark Law Changes to 2021 |
Squire Patton Boggs (US) LLP |
Sep 29 2020 |
Privacy Considerations For COVID-19 Digital Contact Tracing |
McDermott Will & Schulte LLP |
Sep 29 2020 |
CMS'S Proposed Phase-Out of the Inpatient Only List is not Entirely Welcome News |
K&L Gates LLP |
Sep 28 2020 |
Opioid Update: Sixth Circuit Reverses Order Certifying a Negotiation Class |
Squire Patton Boggs (US) LLP |
Sep 28 2020 |
HRSA Issues Proposed Rule Requiring Community Health Center Grant Recipients to Provide Certain Drugs to Low-Income Patents at 340B Prices |
McDermott Will & Schulte LLP |
Sep 28 2020 |
Government Ropes English Employers Into New Self-Isolation Push |
Squire Patton Boggs (US) LLP |
Sep 28 2020 |
Final Canadian Drug Importation Rule and HHS Certification Issued Under Section 804 of the Food, Drug and Cosmetic Act |
Mintz |
Sep 28 2020 |
Updates to Mental Health Parity in California and Nationwide [Podcast] |
K&L Gates LLP |
Sep 28 2020 |
Orphan Drug Exclusivity for CRISPR/Cas-Based Therapeutics |
Proskauer Rose LLP |
Sep 28 2020 |
Premera Blue Cross’s $6.85 Million Settlement is the Second-Largest HIPAA Settlement to Date |
Strassburger McKenna Gutnick & Gefsky |
Sep 26 2020 |
340B UPDATE: Congress and the Administration Respond to Drug Manufacturers' 340B Contract Pharmacy Actions |
K&L Gates LLP |